Permeation and skin absorption: Reproducibility of various industrial reconstructed human skin models

被引:42
作者
Lotte, C [1 ]
Patouillet, C [1 ]
Zanini, M [1 ]
Messager, A [1 ]
Roguet, R [1 ]
机构
[1] LOreal, Life Sci, Adv Res Labs, F-93601 Aulnay Sous Bois, France
来源
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY | 2002年 / 15卷
关键词
human skin models; EpiDerm (R); Episkin (R); SkinEthic (R); permeation; skin absorption; lauric acid; caffeine; mannitol; reproducibility;
D O I
10.1159/000066679
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Human reconstructed skin models could be very useful tools to quantify percutaneous permeation and absorption. Before using such models, the reproducibility in the same batch and/or various batches, i.e. the relevance of the results obtained, must be verified. The reproducibility of 3 industrial models - EpiDerm(R), Episkin(R) and SkinEthic(R) - was tested regarding the permeation and skin absorption of 3 topically applied compounds (with a large range of physicochemical properties): lauric acid, caffeine and mannitol. For all the models, the intrabatch reproducibility was greater than the interbatch re-producibility. According to the batches tested, the larger difference in terms of reproducibility between the 3 models was observed in the case of mannitol, a very poor permeant. In this case, the best reproducibility was observed with EpiDerm and Episkin. Moreover, the rank order of the 3 compounds applied, in terms of permeation and skin absorption, was the same as that expected from ex vivo human skin. Such results revealed human skin models as a promising means to test in vitro permeation and percutaneous absorption of topical products. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:18 / 30
页数:13
相关论文
共 10 条
[1]   Skin culture model: A possible alternative to the use of excised human skin for assessing in vitro percutaneous absorption [J].
Doucet, O ;
Garcia, N ;
Zastrow, L .
TOXICOLOGY IN VITRO, 1998, 12 (04) :423-430
[2]  
DOUCET O, 1995, FACTS ILLUSIONS COSM, P391
[3]  
LOTTE C, UNPUB HDB EUROPEAN P
[4]  
LOTTE C, 1997, PERSPECTIVES PERCU B, V5, P133
[5]   BARRIER FUNCTION OF HUMAN SKIN AND HUMAN RECONSTRUCTED EPIDERMIS [J].
REGNIER, M ;
CARON, D ;
REICHERT, U ;
SCHAEFER, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (04) :404-407
[6]  
Robert M, 1997, SKIN PHARMACOL, V10, P247
[7]   THE USE OF IN-VITRO RECONSTITUTED HUMAN SKIN IN DERMOTOXICITY TESTING [J].
ROGUET, R ;
REGNIER, M ;
COHEN, C ;
DOSSOU, KG ;
ROUGIER, A .
TOXICOLOGY IN VITRO, 1994, 8 (04) :635-&
[8]  
Roguet R., 1995, In Vitro Toxicology, V8, P97
[9]  
ROGUET R, 1999, 3 WORLD C ALT AN US
[10]  
YANG JJ, 1992, IN VITRO TOXICOL, V5, P211